Share chart Danaher Corporation
Extended chart
Simple chart
About Danaher Corporation
Danaher Corporation — глобально диверсифицированный конгломерат со штаб-квартирой в Вашингтоне, округ Колумбия, США. Danaher занимает 162-е место в списке Fortune 500 в 2018 году. Ее продукция сосредоточена в области проектирования, производства и маркетинга промышленной, медицинской и потребительской продукции.Main settings
IPO date
1979-01-05
ISIN
US2358511028
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0.551
Дивиденд ао
0.64
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 7.09 | 1 |
| P/BV | 3.42 | 5 |
| P/E | 43.42 | 4 |
Efficiency
| Title | Value | Grade |
| ROA | 4.81 | 1 |
| ROE | 7.57 | 2 |
| ROIC | 10.6 | 4 |
Dividends
| Title | Value | Grade |
| Dividend yield | 0.4794 | 1.2 |
| DSI | 0.9286 | 9.29 |
| Average dividend growth | 8.78 | 10 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | 3.29 | 4 |
| Debt/Ratio | 0.2064 | 10 |
| Debt/Equity | 0.5649 | 9 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 7.16 | 1 |
| Yield Ebitda, % | -20.54 | 0 |
| Yield EPS, % | 4.32 | 1 |
Dividends
| Dividend, % | Dividend | Result of period | Buy before | Register closing date | Payment before |
| 0.15% | 0.319 | IV кв. 2024 | 26.03.2025 | 28.03.2025 | 14.04.2025 |
| 0.13% | 0.27 | III кв. 2024 | 25.12.2024 | 27.12.2024 | 13.01.2025 |
| 0.11% | 0.27 | II кв. 2024 | 25.09.2024 | 27.09.2024 | 14.10.2024 |
| 0.1% | 0.27 | I кв. 2024 | 26.06.2024 | 28.06.2024 | 15.07.2024 |
| 0.11% | 0.27 | IV кв. 2023 | 25.03.2024 | 27.03.2024 | 11.04.2024 |
| 0.11% | 0.24 | III кв. 2023 | 26.12.2023 | 28.12.2023 | 12.01.2024 |
| 0.12% | 0.27 | I кв. 2023 | 27.06.2023 | 29.06.2023 | 14.07.2023 |
| 0.11% | 0.27 | IV кв. 2022 | 28.03.2023 | 30.03.2023 | 14.04.2023 |
| 0.1% | 0.25 | III кв. 2022 | 27.12.2022 | 29.12.2022 | 13.01.2023 |
| 0.1% | 0.25 | II кв. 2022 | 27.09.2022 | 29.09.2022 | 14.10.2022 |
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 205.1 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| Week | 196.02 $ | 0 $ | 0 $ | 4.63 % | 0 % | 0 % |
| Month | 187.48 $ | 184.54 $ | 205.1 $ | 9.4 % | 0 % | 0 % |
| Three month | 191.89 $ | 174.64 $ | 210.41 $ | 6.88 % | 0 % | 0 % |
| Half a year | 215.01 $ | 174.64 $ | 250.59 $ | -4.61 % | 0 % | 0 % |
| Year | 268.07 $ | 174.64 $ | 280.76 $ | -23.49 % | 0 % | 0 % |
| 3 years | 269.42 $ | 174.64 $ | 301.51 $ | -23.87 % | 0 % | 0 % |
| 5 years | 226.27 $ | 170.22 $ | 333.25 $ | -9.36 % | 0 % | 0 % |
| 10 years | 79.16 $ | 64.36 $ | 333.25 $ | 159.1 % | 0 % | 0 % |
| Year to date | 206.76 $ | 174.64 $ | 250.59 $ | -0.8 % | 0 % | 0 % |
Insider trading
| Insider | Transaction date | Date of disclosure | Type | Price | Volume | Quantity | Share before, % | Share after, % | Document |
| RALES STEVEN M Officer |
12.05.2025 | 12.05.2025 | Purchase | 194.82 | 243 525 000 | 1250000 | 0 | 0.17 | link |
| Riley Christopher Paul Officer |
30.04.2025 | 30.04.2025 | Purchase | 198 | 3 129 390 | 15805 | 0 | 0 | link |
| Glenstone Foundation See Remarks |
24.04.2025 | 24.04.2025 | Purchase | 196.5 | 117 562 000 | 598281 | 0 | 0.08 | link |
| SPOON ALAN G Director |
07.02.2025 | 07.02.2025 | Purchase | 206.46 | 113 553 | 550 | 0 | 0 | link |
| Weidemanis Joakim Executive Vice President |
25.04.2024 | 26.04.2024 | Sale | 250.46 | 5 618 570 | 22433 | 0 | 0 | link |
| Weidemanis Joakim Executive Vice President |
25.04.2024 | 26.04.2024 | Purchase | 58.48 | 1 311 880 | 22433 | 0 | 0 | link |
| Zerhouni Elias A. Director |
28.07.2023 | 01.08.2023 | Purchase | 50.8 | 177 292 | 3490 | 0 | 0 | link |
| Raskas Daniel SVP - Corporate Development |
28.07.2023 | 01.08.2023 | Sale | 260.65 | 2 922 670 | 11213 | 0 | 0 | link |
| Raskas Daniel SVP - Corporate Development |
28.07.2023 | 01.08.2023 | Purchase | 56.7 | 635 777 | 11213 | 0 | 0 | link |
| LOHR WALTER G Director |
05.05.2023 | 08.05.2023 | Sale | 240.88 | 840 671 | 3490 | 0 | 0 | link |
| LOHR WALTER G Director |
05.05.2023 | 08.05.2023 | Purchase | 50.8 | 177 292 | 3490 | 0 | 0 | link |
| SPOON ALAN G Director |
25.10.2022 | 26.10.2022 | Sale | 252.93 | 126 465 | 500 | 0 | 0 | link |
| SPOON ALAN G Director |
25.10.2022 | 26.10.2022 | Purchase | 50.8 | 177 292 | 3490 | 0 | 0 | link |
| Weidemanis Joakim Executive Vice President |
25.07.2022 | 26.07.2022 | Sale | 271.13 | 3 253 560 | 12000 | 0 | 0 | link |
| SCHWIETERS JOHN T Director |
13.07.2022 | 14.07.2022 | Purchase | 38.64 | 175 735 | 4548 | 0 | 0 | link |
| Weidemanis Joakim Executive Vice President |
25.04.2022 | 27.04.2022 | Sale | 255.74 | 1 662 310 | 6500 | 0 | 0 | link |
| Weidemanis Joakim Executive Vice President |
30.07.2021 | 02.08.2021 | Sale | 298.93 | 2 002 830 | 6700 | 0 | 0 | link |
| McGrew Matthew EVP & Chief Financial Officer |
28.07.2021 | 29.07.2021 | Sale | 293.4 | 3 611 750 | 12310 | 0 | 0 | link |
| McGrew Matthew EVP & Chief Financial Officer |
28.07.2021 | 29.07.2021 | Purchase | 46.13 | 567 860 | 12310 | 0 | 0 | link |
| Ellis Brian W SVP and General Counsel |
28.07.2021 | 29.07.2021 | Sale | 291 | 3 492 000 | 12000 | 0 | 0 | link |
| Ellis Brian W SVP and General Counsel |
28.07.2021 | 29.07.2021 | Purchase | 65.95 | 791 400 | 12000 | 0 | 0 | link |
Main owners
| Institutions | Volume | Share, % |
| Vanguard Group Inc | 55 943 373 | 7.55 |
| Blackrock Inc. | 50 772 596 | 6.86 |
| Wellington Management Group, LLP | 27 928 442 | 3.77 |
| State Street Corporation | 27 509 575 | 3.71 |
| FMR, LLC | 22 350 888 | 3.02 |
| Morgan Stanley | 19 654 901 | 2.65 |
| Price (T.Rowe) Associates Inc | 16 757 558 | 2.26 |
| Capital International Investors | 15 956 519 | 2.15 |
| Geode Capital Management, LLC | 12 506 813 | 1.69 |
| JP Morgan Chase & Company | 10 292 928 | 1.39 |
Contained in ETF
| ETF | Share, % | Profitability for 1 year, % | Commission, % |
| Alpha Intelligent - Large Cap Growth ETF | 5.86 | 0 | 0.85 |
| iShares Evolved U.S. Healthcare Staples ETF | 4.98 | 31.23 | 0.18 |
| Pacer BioThreat Strategy ETF | 4.83531 | 6.83 | 0.7 |
| Harbor Disruptive Innovation ETF | 3.07987 | 11.58 | 0.75 |
| AVDR U.S. LargeCap ESG ETF | 2.78 | 0 | 0.60 |
| John Hancock Multifactor Healthcare ETF | 2.35 | 29.34 | 0.40 |
| Knowledge Leaders Developed World ETF | 1.10573 | -2.72 | 0.75 |
| Fidelity Growth Opportunities ETF | 0.73975 | -7.91 | 0.38 |
| iShares Morningstar Large-Cap Value ETF | 0.67671 | 53.47 | 0.25 |
| Columbia U.S. ESG Equity Income ETF | 0.67505 | -3.6 | 0.35 |
| iShares Morningstar Large-Cap ETF | 0.34944 | 184.21 | 0.03 |
| JPMorgan U.S. Aggregate Bond ETF | 0.01 | 5.07 | 0.07 |
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Mr. Steven M. Rales | Co-Founder & Chairman | N/A | 1951 (74 years) |
| Mr. Rainer M. Blair | President, CEO & Director | 5.33M | 1964 (61 year) |
| Mr. Mitchell P. Rales | Co-Founder & Director | N/A | 1957 (68 years) |
| Mr. Matthew R. McGrew | CFO & Executive VP | 2.56M | 1972 (53 years) |
| Mr. Joakim Weidemanis | Executive Officer | 2.76M | 1969 (56 years) |
| Dr. Jose-Carlos Gutierrez-Ramos Ph.D. | Senior VP & Chief Science Officer | 2.09M | 1962 (63 years) |
| Mr. Christopher M. Bouda | VP & Chief Accounting Officer | N/A | |
| Mr. John Bedford | Vice President of Investor Relations | N/A | |
| Mr. Brian W. Ellis | Senior VP, General Counsel & Chief Compliance Officer | 1.93M | 1967 (58 years) |
| Ms. Georgeann F. Couchara | Senior Vice President of Human Resources | 1.66M | 1977 (48 years) |
About company
Address: United States, Washington, 2200 Pennsylvania Avenue NW - Open in google maps, Open in yandex maps
Website: http://www.danaher.com
Website: http://www.danaher.com
